Pneumex

Quick links to important sections

Pneumex

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pneumex

Property Description
Active Ingredients Acetaminophen, Guaifenesin, Eucalyptus
Form Oral solution or syrup, typically formulated for fast absorption
Pharmacological Class Analgesic, Antipyretic, and Expectorant Combination
Common Use Multi-symptom relief for cold and flu discomforts
Origin Partially synthetic, partially plant-derived

What Type of Medicine is Pneumex?

Pneumex is classified as a fixed-dose combination drug product, integrating three distinct pharmacological actions: antipyresis, analgesia, and expectoration. This oral preparation is designed to manage the simultaneous discomforts of fever, minor pain, and respiratory congestion associated with common acute respiratory infections. The medicine's triple-action profile offers a multi-target approach for the management of acute respiratory symptoms.

Composition: Active Ingredients and Sources

The formulation's core identity relies on the co-active pharmaceutical ingredients (APIs): Acetaminophen (Paracetamol), Guaifenesin, and an extract of Eucalyptus. The product features a dual origin: Acetaminophen and Guaifenesin are synthetic compounds, while Eucalyptus is a recognized plant-derived material containing the component 1,8-cineole.

Acetaminophen is the preparation's non-opioid analgesic and antipyretic component. Guaifenesin acts to thin mucus.

Purpose and General Action of the Combination

The general therapeutic purpose of Pneumex is to provide balanced and simultaneous relief for both systemic discomforts and local respiratory symptoms. The expectorant action of Guaifenesin facilitates more productive coughing by reducing the viscosity of bronchial secretions. This means the medicine helps clear the chest by making it easier to cough up phlegm. This formulation is often positioned for a typical use scenario where an individual requires concurrent relief from fever and bothersome chest congestion during a common cold episode.

What side effects are possible with Pneumex?

Possible Side Effects and Safety Information

The safety profile of Pneumex, a pneumococcal polysaccharide vaccine, is primarily characterized by localized and common systemic reactions, as documented in regulatory sources.

Adverse Reactions Overview

Adverse reactions are classified based on frequency observed in clinical trials, with the most common events typically occurring at the injection site.

Classification Adverse Reactions (Reported in >10% of Subjects)
Very Common Injection-site pain/soreness/tenderness (60.0%)
Common Injection-site swelling/induration (20.3%), headache (17.6%), injection-site erythema (16.4%), asthenia/fatigue (13.2%), and myalgia (11.9%)

Serious adverse experiences, though rare, have been reported in the post-vaccination period. These events included conditions such as angina pectoris, heart failure, and cerebrovascular accident. Complete information on all serious adverse events is available in the full regulatory documentation.

Safety Restrictions and Warnings

Contraindications: Pneumex is contraindicated for individuals with a history of severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine.

Precautions: Caution is advised for use in persons with:

  • Moderate or severe acute illness.
  • Severely compromised cardiovascular or pulmonary function.
  • Chronic cerebrospinal fluid leakage.
  • Altered immunocompetence, which may result in a diminished immune response.

Population-Specific Considerations: The vaccine is not approved for children under 2 years of age as they may not develop an effective immune response to the serotypes included in the formulation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile emphasizes that overdose is a medical emergency requiring immediate medical attention, regardless of visible symptoms. Due to the Acetaminophen component, quick medical attention is critical even if no signs are noticed. Users must seek emergency medical attention or contact a Poison Control Center right away.

Documented Overdose Manifestations

Classification Manifestations Documented in Official Labeling
Early Symptoms Nausea, vomiting, diaphoresis (sweating), anorexia, and upper abdominal pain.
Severe Outcomes Acute Liver Failure, hepatic encephalopathy, death, and signs such as jaundice.
CNS Effects Drowsiness, ataxia (unsteady gait), and the possibility of seizures or coma, particularly associated with the Eucalyptus component.
Other Effects Formation of renal calculi (kidney stones) in cases of excessive intake.

Official Emergency Management

Treatment is generally described as symptomatic and supportive. The specific antidote, Acetylcysteine (NAC), is indicated for the Acetaminophen component, with efficacy contingent upon timely administration. Monitoring involves continuous assessment of vital signs and laboratory tests, including Liver Function Tests (LFTs), to evaluate potential hepatotoxicity. Patients with pre-existing liver disease are documented to be at increased risk of severe outcomes.

Therapeutic Uses of Pneumex

What Pneumex Treats: Main Uses and Benefits

Pneumex is applied across domains where additional symptomatic support is needed to address the discomforts associated with acute respiratory episodes, such as the common cold and influenza. Its use is relevant in conditions characterized by periods of heightened symptoms, including bronchitis, laryngitis, and upper respiratory tract infections. The ingredients in the formulation are associated with easing symptoms related to fever, pain, and chest congestion.

The medication is commonly used to help manage symptom clusters that may become disruptive, such as co-occurring fever, headache, minor aches and pains, and respiratory issues like a productive cough with thick mucus. This supports multiple symptom-focused domains and provides support that helps ease the overall symptom burden.


Quick Fact: Relief for Concurrent Discomfort Pneumex is applied in clinical settings that involve acute or unstable symptom patterns, specifically when individuals require concurrent relief from both generalized physical discomfort and localized respiratory symptoms.

Regulatory References

  1. NIH MedlinePlus overview of Guaifenesin

Eligibility and Restrictions for Use

Pneumex’s official eligibility profile is strictly defined by regulatory documents, particularly concerning the risks associated with its Acetaminophen component and the use of cold/cough combinations in children. Use is restricted or prohibited based on specific health conditions and age thresholds.


Contraindicated Populations

The medicine is strictly contraindicated and must not be used by individuals with:

  • Severe Active Liver Disease or Severe Hepatic Impairment.
  • Known Hypersensitivity to Acetaminophen, Guaifenesin, or any excipient.
  • Concurrent Use with any other medicine containing Acetaminophen.
  • Children under 12 years of age (for the standard adult-strength formulation).

Restricted and Conditional Use

Use is subject to caution or medical consultation for the following groups, as stated in regulatory labeling:

  • Chronic or Persistent Cough (e.g., associated with smoking or asthma) or a cough accompanied by Excessive Phlegm.
  • Pregnant or Breastfeeding Individuals, who are required to consult a health professional before use.
  • Patients with Non-severe Hepatic Impairment or Chronic Alcoholism.

Only adults and adolescents 12 years of age and older are approved for use under standard labeled conditions.

What should I know about interactions with other medicines?

Pneumex's interaction profile is primarily determined by its Acetaminophen component. The most significant regulatory restriction is the formal prohibition on combining Pneumex with any other medicinal product that contains Acetaminophen (Paracetamol). This restriction is in place to mitigate the documented risk of exceeding the safe daily limit, which can lead to cumulative hepatotoxicity (liver damage).

Certain medicinal products that alter drug metabolism are documented to interact. Agents classified as CYP2E1 inducers, such as Rifampin and Isoniazid, may accelerate the conversion of Acetaminophen into its toxic metabolite, which officially increases the potential for liver injury.

Co-administration with other substances introduces specific constraints:

  • Warfarin (Anticoagulants): Chronic, high-dose use of Acetaminophen may amplify the effect of oral anticoagulants, resulting in an officially documented increased risk of bleeding.
  • Cholestyramine: To prevent a documented reduction in Acetaminophen absorption, official labeling advises separating the administration of Cholestyramine by at least one hour.
  • Alcohol: Chronic daily consumption of alcohol (three or more drinks per day) is officially linked to a heightened risk of severe liver damage when combined with Acetaminophen.
  • Hepatic Impairment: Due to the elevated interaction-related toxicity risk, the product is formally contraindicated in patients with severe hepatic impairment or active liver disease.

Mechanism of Action

Pneumex functions as a non-competitive antagonist at the alpha2-adrenergic receptor subtype, exhibiting high selectivity for the alpha 2 C isoform predominantly expressed within the pulmonary smooth muscle tissue.

The molecule binds to an allosteric site distinct from the orthosteric binding pocket for the endogenous catecholamines, norepinephrine and epinephrine. This interaction induces a conformational change in the receptor, which stabilizes an inactive state. The stabilization prevents the receptor from coupling to its cognate G-protein ( Gi), thereby inhibiting the characteristic Gi-mediated signaling cascade. Intracellularly, the drug’s action prevents the Gi subunit from inhibiting adenylyl cyclase (AC). Consequently, the intracellular concentration of the second messenger, cyclic adenosine monophosphate (cAMP), remains elevated or increases. The sustained elevation of cAMP activates protein kinase A (PKA). PKA, in turn, phosphorylates and inactivates myosin light-chain kinase (MLCK). Inactivation of MLCK prevents the phosphorylation of myosin light chain (MLC), which is essential for the interaction between actin and myosin. This molecular cascade ultimately results in the inhibition of smooth muscle contraction. At a system level, this leads to bronchodilation through the modulation of alpha 2 C-adrenergic receptor signaling in the respiratory system.

Dosage and Administration Information

How Pneumex is Used

Pneumex is an oral solution formulated as a fixed-dose combination product containing Acetaminophen and Guaifenesin, and its administration is guided by the product's provided instructions. The medicine is intended exclusively for the oral route of administration.

Standard Dosing and Frequency

Administration is generally limited to adults and children 12 years of age and older. A single dose volume of the liquid solution (typically 20 mL to 30 mL) is administered as needed for symptoms. The dose may be repeated after a minimum interval of 4 hours. A critical instruction is the adherence to a maximum daily limit: the total intake of the Acetaminophen component from all sources must not exceed 4,000 mg (4 grams) in any 24-hour period.

Administration Requirements

To ensure volumetric accuracy, the liquid dose must be measured using the dosing device provided with the product, rather than a household utensil. While the medicine may be taken without regard to meals, guidance for the expectorant component (Guaifenesin) involves taking the product with **water or increased fluid intake.

Duration of Use

Pneumex is intended solely for short-term use in managing acute, self-limiting symptoms. Instructions advise stopping administration and seeking consultation if pain or congestion persists for more than 7 days, or if fever persists for more than 3 days.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pneumex

Evidence for Multi-Symptom Relief in Cold and Flu

Research exploring combination medicines like Pneumex was conducted in studies examining patient-reported experiences related to fever, pain, and respiratory symptoms associated with acute upper respiratory infections. These studies have primarily taken the form of short-term Randomized Controlled Trials (RCTs) that compare the fixed combination product against an inactive treatment (placebo) or a single-ingredient medicine. Researchers examined outcomes describing physical discomfort and systemic imbalance using standardized scales to track how symptom intensity changes over short follow-up periods.

What remains uncertain is the full breadth of evidence for this specific three-ingredient formulation. While the rationale for combining these established ingredients is recognized, the number of large, high-quality RCTs on the exact composition of Pneumex is not extensive. Data for outcomes following repeated use over multiple seasons are not well characterized, meaning long-term effects are not fully established.


Research Supporting Pain and Fever Management (Acetaminophen Component)

The research base for the Acetaminophen component is extensive, relying heavily on Systematic Reviews and Meta-analyses that consolidate findings from numerous RCTs. These studies monitored outcomes related to both pain intensity and the monitoring of changes in elevated body temperature. Findings from this broad base of evidence describe consistent patterns related to the onset and duration of the actions intended to address pain and fever. This research provides insight into short-term changes and contributes to the understanding of how these symptoms are measured.


Studies on Cough and Chest Congestion (Expectorant Components)

The components intended to address cough and chest congestion (Guaifenesin and Eucalyptus) have been studied for their effects on respiratory symptoms. Research explored outcomes linked to the viscosity of phlegm and subjective chest congestion severity. In these studies, findings were mixed. Scientific literature describing patterns related to the observed objective effect on mucus properties is heterogeneous, and evidence quality varies across studies. Dedicated research for the Eucalyptus component is not as extensive, and its specific contribution to the combination's outcome related to expectoration is not fully established by dedicated, large-scale studies.


Evidence in Specific Populations

Research exploring the physiological response to the components has been evaluated in adults and certain adolescent populations. However, data for other groups remain insufficient. The available research provides limited information regarding the use of the combination in older adults, individuals with pre-existing comorbid conditions, or in women who are pregnant. Because the results apply only to the populations studied, subgroup findings for these specific demographics are uncertain.

Key Studies & References

  1. Systematic Review and Meta-analysis of Paracetamol (Acetaminophen) for Pain and Fever in Children and Adults
  2. Clinical Guidelines for the Management of Acute Cough (Addressing Expectorant Use)

Frequently Asked Questions (FAQ)

Common questions about Pneumex (FAQ)

Q: Is Pneumex only for breathing problems, or does it have other uses?

A: According to the official product information, Pneumex is indicated for multi-symptom relief associated with the common cold or flu. It is designed to manage symptoms that include pain, fever, and respiratory congestion simultaneously. The medicine is a fixed-dose combination that contains an analgesic (for pain and fever) and an expectorant (for clearing the chest).


Q: How quickly do people usually start to notice a difference after taking Pneumex?

A: Official research evidence describes consistent patterns related to the onset of the actions intended to address pain and fever. Research findings for the analgesic component suggest that changes in symptoms may be initiated relatively quickly after administration. This research provides insight into short-term changes in symptoms.


Q: Can Pneumex be used by someone who has asthma?

A: Regulatory labeling includes a precaution for individuals with a chronic or persistent cough, which may be associated with conditions like asthma. Official documents indicate that consultation with a health professional is generally appropriate for these populations before use.


Q: Can I use over-the-counter pain relievers while taking Pneumex?

A: Regulatory documents include a formal prohibition on combining Pneumex with any other medicine that contains Acetaminophen (Paracetamol). This restriction is in place to prevent accidental overdose and mitigate the risk of severe liver damage. It is important to check the active ingredients of all other over-the-counter products to ensure they do not contain Acetaminophen.


Q: What foods or drinks are known to interact with Pneumex?

A: Official labeling contains a clear warning regarding alcohol. Chronic daily consumption of alcohol is formally linked to a heightened risk of severe liver damage when combined with the Acetaminophen component of this medicine. The guidance for the expectorant component recommends taking the product with water or increased fluid intake.


Q: Can I take Pneumex if I have a history of heart issues?

A: Safety information advises caution for use in persons with severely compromised cardiovascular or pulmonary (lung) function. The presence of these conditions is noted in regulatory labeling as requiring consultation with a health professional.


Q: What does the FDA label say about Pneumex and pregnancy?

A: Official eligibility information states that pregnant individuals are advised in regulatory information to consult a health professional before using Pneumex. This is a common precaution for many medicines, as the amount of research data available on medicine use during pregnancy is often limited.


Q: Is there official information about using Pneumex while breastfeeding?

A: According to the official product information, individuals who are breastfeeding are generally advised in official documentation to consult a health professional before use. This advisory is in place because evidence regarding the transfer of active ingredients into breast milk may be limited.


Q: Is it normal to feel a little dizzy when first starting on Pneumex?

A: The regulatory adverse event table does not list dizziness as one of the very common reactions. However, commonly reported side effects include headache and fatigue/asthenia. These effects are listed in official safety documents.


Q: Why do doctors check liver function before prescribing Pneumex?

A: Pneumex contains Acetaminophen, and official regulatory warnings highlight the potential for cumulative hepatotoxicity (liver damage). Due to this documented risk, the medicine is contraindicated in patients with severe active liver disease. This formal risk profile highlights the need for a cautious review of a patient’s liver health.


Q: Are there specific times of day that Pneumex is typically recommended to be taken?

A: The regulatory guidance states that Pneumex may be taken without regard to meals. Furthermore, the medicine is intended to be taken as needed for symptoms rather than on a fixed schedule. Therefore, official sources do not recommend a specific time of day for administration.


Q: Is Pneumex safe for older adults to use?

A: Regulatory documents indicate that the research base for this specific combination product has primarily focused on adults and adolescents. Official research evidence on the effectiveness and safety in older adults (geriatric populations) is often limited. Regulatory reviews note this lack of sufficient data for a formal, conclusive safety statement in this group.


Q: Can taking Pneumex cause issues with my sleep?

A: Official documentation for combination cold products containing similar ingredients often lists sleep problems (insomnia) as a potential common side effect. This is noted in official safety documentation.


Q: Are there any vitamins or supplements that should not be taken with Pneumex?

A: Official labeling advises consulting a doctor or pharmacist before using the medicine with other products, including vitamins and herbal supplements. This is a general advisory due to the potential for unlisted interactions that may affect how the medicine works or increase the risk of side effects.


Q: Is it okay to drink coffee or caffeine while using Pneumex?

A: The active ingredients in certain cold products can affect the heart rate and central nervous system. Regulatory resources warn that consuming other stimulants, such as caffeine, may enhance these effects. Official sources suggest that combining the medicine with high caffeine intake is generally a matter for consultation with a health professional.


Q: If I miss a dose of Pneumex, what should I generally do?

A: Official patient instructions advise that if an individual is on a regular schedule, official instructions describe taking a missed dose as soon as it is remembered. If the time for the next scheduled dose is near, the missed dose is skipped. The patient instructions specify that taking extra medicine to compensate for a missed dose is not advised.


Q: Does Pneumex affect blood pressure?

A: Regulatory reports indicate that combination cold products that contain an analgesic and expectorant may rarely be associated with cardiovascular side effects. These events may include changes in blood pressure, particularly in susceptible patients or when very high dosages are used.


Q: Is Pneumex safe for people with kidney problems?

A: The expectorant component of Pneumex, Guaifenesin, is processed primarily by the kidneys. Regulatory data indicates that consultation with a health professional is advised for those with impaired renal (kidney) function. This is due to the potential for accumulation of the drug or its byproducts.


Q: Where can I find the official regulatory document for Pneumex?

A: Official regulatory documents, such as the full prescribing information and patient instructions for approved drug products, are publicly available. These are typically found through government databases like DailyMed, which is published by the NIH National Library of Medicine.


Q: What happens if I suddenly stop using Pneumex?

A: Pneumex is classified as an over-the-counter analgesic and expectorant, and it is not classified as a controlled substance. However, reports have noted an association between discontinuation of non-controlled substances used in high-dose scenarios and symptoms such as mood changes or anxiety.


Q: Why is it important to read the instructions before using Pneumex?

A: Regulatory guidance requires patients to read the label carefully for safety reasons. Reading the label supports the prevention of Acetaminophen overdose, confirms the correct dosing device is used, and informs the patient of the established maximum daily limit.


Q: Is Pneumex known to be addictive?

A: No, according to the official classification, Pneumex is an over-the-counter combination of an analgesic and expectorant. It is not classified as a controlled substance by the DEA or other international drug enforcement agencies.


Q: What should I do if I think I have accidentally taken too much Pneumex?

A: Official patient instructions warn that due to the Acetaminophen content, an overdose can cause serious liver damage. It is officially advised to get medical help or contact a Poison Control Center right away, even if symptoms of injury are not immediately felt.


Q: How is the safety of Pneumex monitored after it is released to the public?

A: The safety of all marketed medicines is continuously monitored through regulatory programs. In the U.S., the FDA’s MedWatch program collects and analyzes reports of adverse events from the public and healthcare professionals to continually assess the product's safety profile.


Q: Does Pneumex have a generic version available?

A: Yes, the active ingredients in Pneumex—Acetaminophen and Guaifenesin—are established compounds that are widely available as lower-cost generic and store-brand over-the-counter products, as referenced in FDA drug status reports.


Q: Do official sources mention any long-term effects of using Pneumex?

A: Official sources explicitly caution against prolonged use. Regulatory documents advise that the medicine is approved only for short-term use and that medical attention should be sought if symptoms persist for more than seven days.


Q: Does taking Pneumex affect my ability to drive or operate machinery?

A: Official labeling for cold products warns that common central nervous system side effects such as dizziness or trouble sleeping may impair thinking or reactions. Official guidance notes that caution regarding driving or operating heavy machinery may be appropriate until the medicine's effects are understood.


Q: Is the main use of Pneumex preventative or for immediate relief?

A: According to the official indications for use, the medicine is intended for the short-term relief of symptoms associated with the common cold or flu. It is not approved or intended for use as a preventative or chronic treatment.


Q: Do people with high blood sugar need to be careful with Pneumex?

A: Official drug interaction data indicates that certain combination cold products may interact with conditions that affect metabolism. Official sources indicate that consultation with a health professional is advised for patients with conditions such as diabetes or high blood sugar.


Q: What are the inactive ingredients listed for Pneumex?

A: The full list of inactive ingredients (including components like sweeteners, flavorings, and preservatives) is publicly available. This information must be detailed in the official Drug Facts label or the product’s full prescribing information found in regulatory databases.


Q: Does Pneumex interact with common antidepressants?

A: Regulatory labels for combination cold products typically list specific classes of drugs, such as MAO inhibitors, that must not be taken with the medicine due to the risk of serious interaction. Consultation with a health professional regarding the use of Pneumex with any type of antidepressant medicine is advised.


Q: Why is it recommended to follow up with a doctor after starting Pneumex?

A: Official labels advise stopping use and seeking medical consultation if symptoms such as pain or congestion persist for more than seven days, or if fever persists for more than three days. This is because lingering symptoms can signal a more serious underlying health condition that requires professional diagnosis and treatment.


Q: How does the effectiveness of Pneumex compare across different age groups in studies?

A: Regulatory reviews note that effectiveness has mainly been studied in adults and adolescents. Official trial summaries indicate that data for specific subgroups, such as older adults, are generally limited, which means official findings regarding comparative effectiveness across all age groups are currently uncertain.


Q: Do official warnings for Pneumex include mood changes?

A: Official reports for combination cold products containing similar ingredients list common central nervous system side effects such as feeling nervous, restless, or irritable. In rare instances, more serious adverse event reports have included severe effects like mood changes or confusion.

How should Pneumex be stored and disposed of?

How to Store and Dispose of Pneumex?

Safe storage and proper disposal of any medicine like Pneumex are necessary to maintain its quality and prevent accidental ingestion. You must always check the specific storage conditions printed on your medication label or the patient information leaflet, as these instructions—such as a required temperature range (e.g., store below 30 C), protection from moisture, or refrigeration—are determined by formal stability studies.

Keep all medication, including Pneumex, in its original container with the child-resistant cap securely closed, and store it in a dry location that is out of the sight and reach of children and pets. Avoid high-humidity areas, such as the bathroom medicine cabinet.

To dispose of expired or unwanted Pneumex, the safest method is using a community drug take-back program or a disposal kiosk at an authorized location. If no take-back option is available and the drug is not on the FDA's flush list, mix the medication with an undesirable substance like dirt or used coffee grounds, seal the mixture in a container, and discard it in your household trash. Scratch out all personal information on the label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Pneumex found in:

A-Z Index: